Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Chronic Heart Failure

  Free Subscription

Articles published in Heart

Retrieve available abstracts of 179 articles:
HTML format

Single Articles

    April 2024
  1. CUTHBERT JJ, Soyiri I, Lomax SJ, Turgoose J, et al
    Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Heart. 2024 Apr 17:heartjnl-2023-323577. doi: 10.1136/heartjnl-2023-323577.
    PubMed     Abstract available

    March 2024
  2. MERCADE-BESORA N, Li X, Kolde R, Trinh NT, et al
    The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.
    Heart. 2024 Mar 12:heartjnl-2023-323483. doi: 10.1136/heartjnl-2023-323483.
    PubMed     Abstract available

    February 2024
  3. HENDRIKS PM, van den Bosch AE, Kors JA, Geenen LW, et al
    Heart rate: an accessible risk indicator in adult congenital heart disease.
    Heart. 2024;110:402-407.
    PubMed     Abstract available

    January 2024
  4. DOHERTY DJ, Docherty KF, Gardner RS
    Review of the National Institute for Health and Care Excellence guidelines on chronic heart failure.
    Heart. 2024 Jan 8:heartjnl-2022-322164. doi: 10.1136/heartjnl-2022-322164.
    PubMed     Abstract available

    December 2023
  5. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    PubMed     Abstract available

  6. SUC G, Cachier A, Hentic O, Bazire B, et al
    Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
    Heart. 2023;110:132-139.
    PubMed     Abstract available

  7. ALI MR, Lam CSP, Stromberg A, Hand SPP, et al
    Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality.
    Heart. 2023 Dec 1:heartjnl-2023-323295. doi: 10.1136/heartjnl-2023-323295.
    PubMed     Abstract available

    November 2023
  8. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    PubMed     Abstract available

  9. CHOI S, Nah S, Cho YS, Moon I, et al
    Accuracy of visual estimation of ejection fraction in patients with heart failure using augmented reality glasses.
    Heart. 2023 Nov 8:heartjnl-2023-323067. doi: 10.1136/heartjnl-2023-323067.
    PubMed     Abstract available

  10. SANGHA V
    Augmenting reality in echocardiography.
    Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.

    October 2023
  11. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed     Abstract available

  12. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    PubMed     Abstract available

  13. SOTOMI Y, Tamaki S, Hikoso S, Nakatani D, et al
    Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
    Heart. 2023 Oct 12:heartjnl-2023-323059. doi: 10.1136/heartjnl-2023-323059.
    PubMed     Abstract available

  14. Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
    Heart. 2023 Oct 12:heartjnl-2023-323049. doi: 10.1136/heartjnl-2023-323049.
    PubMed     Abstract available

    September 2023
  15. OTTO CM
    Heartbeat: cardiopulmonary fitness as an explanation for the apparent obesity paradox in heart failure mortality risk.
    Heart. 2023;109:1499-1501.

  16. FRITZ J, Belovari K, Ulmer H, Zaruba MM, et al
    Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis.
    Heart. 2023 Sep 18:heartjnl-2023-322803. doi: 10.1136/heartjnl-2023-322803.
    PubMed     Abstract available

  17. ELTAYEB M, Squire I, Sze S
    Biomarkers in heart failure: a focus on natriuretic peptides.
    Heart. 2023 Sep 6:heartjnl-2020-318553. doi: 10.1136/heartjnl-2020-318553.
    PubMed     Abstract available

    August 2023
  18. PONNUSAMY SS, Syed T, Vijayaraman P
    Pacing induced cardiomyopathy: recognition and management.
    Heart. 2023;109:1407-1415.
    PubMed     Abstract available

  19. BRADLEY J, Schelbert EB, Bonnett LJ, Lewis GA, et al
    Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation.
    Heart. 2023 Aug 11:heartjnl-2023-322857. doi: 10.1136/heartjnl-2023-322857.
    PubMed     Abstract available

  20. GRAHAM FJ, Friday JM, Pellicori P, Greenlaw N, et al
    Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease.
    Heart. 2023;109:1294-1301.
    PubMed     Abstract available

  21. CHAN DZ, Grey C, Doughty RN, Lund M, et al
    Widening ethnic inequities in heart failure incidence in New Zealand.
    Heart. 2023 Aug 3:heartjnl-2023-322795. doi: 10.1136/heartjnl-2023-322795.
    PubMed     Abstract available

    July 2023
  22. BEGGS SAS, Wright GA, Gardner RS
    Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.

  23. DIBBEN GO, Hannay JR, Taylor RS
    Exercise training in heart failure.
    Heart. 2023 Jul 17:heartjnl-2022-321132. doi: 10.1136/heartjnl-2022-321132.

  24. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    PubMed     Abstract available

  25. OTTO CM
    Heartbeat: Questionable benefit of beta-blocker therapy more than one year after myocardial infarction in patients without heart failure or ventricular dysfunction.
    Heart. 2023;109:1123-1125.

  26. SCHOPS LB, Sengelov M, Modin D, Jorgensen PG, et al
    Parameters associated with improvement of systolic function in patients with heart failure.
    Heart. 2023 Jul 9:heartjnl-2023-322371. doi: 10.1136/heartjnl-2023-322371.
    PubMed     Abstract available

  27. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    PubMed     Abstract available

    June 2023
  28. YOGESWARAN V, Hidano D, Diaz AE, Van Spall HGC, et al
    Regional variations in heart failure: a global perspective.
    Heart. 2023 Jun 23:heartjnl-2022-321295. doi: 10.1136/heartjnl-2022-321295.
    PubMed     Abstract available

  29. LAVIE CJ, Kokkinos P, Lin GM
    Obesity paradox is still alive in heart failure.
    Heart. 2023 Jun 20:heartjnl-2023-322797. doi: 10.1136/heartjnl-2023-322797.

  30. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    PubMed     Abstract available

  31. FUSCO F, Scognamiglio G
    Heart failure management in adults with congenital heart disease: are we on the 'right path'?
    Heart. 2023 Jun 8:heartjnl-2023-322807. doi: 10.1136/heartjnl-2023-322807.

  32. JONES NR, Ordonez-Mena JM, Roalfe AK, Taylor KS, et al
    Body mass index and survival in people with heart failure.
    Heart. 2023 Jun 8:heartjnl-2023-322459. doi: 10.1136/heartjnl-2023-322459.
    PubMed     Abstract available

  33. CARRERAS-MORA J, Simon-Ramon C, Vidal-Burdeus M, Rodriguez-Sotelo L, et al
    Subclinical congestion assessed by lung ultrasound in ST segment elevation myocardial infarction.
    Heart. 2023 Jun 7:heartjnl-2023-322690. doi: 10.1136/heartjnl-2023-322690.
    PubMed     Abstract available

    May 2023
  34. YOGESWARAN V, Wadden E, Szewczyk W, Barac A, et al
    A narrative review of heart failure with preserved ejection fraction in breast cancer survivors.
    Heart. 2023 May 31:heartjnl-2022-321859. doi: 10.1136/heartjnl-2022-321859.
    PubMed     Abstract available

  35. MORTON G, Moore J
    Systems of care for heart failure: bridging the divide between primary care and specialist services.
    Heart. 2023 May 5:heartjnl-2022-321757. doi: 10.1136/heartjnl-2022-321757.

  36. ISHAK D, Aktaa S, Lindhagen L, Alfredsson J, et al
    Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes.
    Heart. 2023 May 2:heartjnl-2022-322115. doi: 10.1136/heartjnl-2022-322115.
    PubMed     Abstract available

    April 2023
  37. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    PubMed     Abstract available

  38. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    PubMed     Abstract available

  39. MARUT B, Charbonneau E, Curtis E, Donal E, et al
    Will computerised medical records and statistical tools really help us move towards precision medicine of heart failure with preserved ejection fraction?
    Heart. 2023 Apr 17:heartjnl-2023-322475. doi: 10.1136/heartjnl-2023-322475.

    March 2023
  40. JASINSKA-PIADLO A, Campbell P
    Management of patients with heart failure and preserved ejection fraction.
    Heart. 2023 Mar 22:heartjnl-2022-321097. doi: 10.1136/heartjnl-2022-321097.

  41. FORSYTH P, Beezer J, Bateman J
    Holistic approach to drug therapy in a patient with heart failure.
    Heart. 2023 Mar 10:heartjnl-2022-321764. doi: 10.1136/heartjnl-2022-321764.
    PubMed     Abstract available

  42. SCHLENKER KA, Steiner JM
    Expanding perspective: considering opioids in the management of dyspnoea in end-stage heart failure.
    Heart. 2023 Mar 10:heartjnl-2023-322436. doi: 10.1136/heartjnl-2023-322436.

  43. KOSTOPOULOS G, Doundoulakis I, Toulis KA, Karagiannis T, et al
    Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.
    Heart. 2023 Mar 10:heartjnl-2022-322044. doi: 10.1136/heartjnl-2022-322044.
    PubMed     Abstract available

  44. GAERTNER J, Fusi-Schmidhauser T, Stock S, Siemens W, et al
    Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis.
    Heart. 2023 Mar 6:heartjnl-2022-322074. doi: 10.1136/heartjnl-2022-322074.
    PubMed     Abstract available

    February 2023
  45. JORDAN C, Charman SJ, Batterham AM, Flynn D, et al
    Habitual physical activity levels of adults with heart failure: systematic review and meta-analysis.
    Heart. 2023 Feb 27:heartjnl-2022-321943. doi: 10.1136/heartjnl-2022-321943.
    PubMed     Abstract available

  46. WEIR RAP
    Management of hospitalised patients with heart failure admitted to non-cardiology services.
    Heart. 2023 Feb 27:heartjnl-2022-321720. doi: 10.1136/heartjnl-2022-321720.

  47. SOTOMI Y, Hikoso S, Nakatani D, Okada K, et al
    Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.
    Heart. 2023 Feb 23:heartjnl-2022-322181. doi: 10.1136/heartjnl-2022-322181.
    PubMed     Abstract available

  48. MARATEB HR, Mansourian M, Mananas MA
    Correspondence on "Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study" by Pinto-Filho et al.
    Heart. 2023;109:413-414.

  49. PINTO-FILHO MM, Soares CPM, Paixao GM, Ribeiro ALP, et al
    Response to: Correspondence on "Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study" by Marateb et al.
    Heart. 2023;109:414-415.

  50. EDWARD J, Banchs J, Parker H, Cornwell W, et al
    Right ventricular function across the spectrum of health and disease.
    Heart. 2023;109:349-355.
    PubMed     Abstract available

  51. NORHAMMAR A, Bodegard J, Vanderheyden M, Tangri N, et al
    Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
    Heart. 2023 Feb 13:heartjnl-2022-321702. doi: 10.1136/heartjnl-2022-321702.
    PubMed     Abstract available

  52. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    PubMed     Abstract available

    January 2023
  53. STRAW S, Witte KK
    Remote monitoring in heart failure: it's the data you collect and what you do with them.
    Heart. 2023 Jan 26:heartjnl-2022-322137. doi: 10.1136/heartjnl-2022-322137.

  54. ZHUANG S, Huang S, Huang Z, Zhang S, et al
    Prospective study of sleep duration, snoring and risk of heart failure.
    Heart. 2023 Jan 2:heartjnl-2022-321799. doi: 10.1136/heartjnl-2022-321799.
    PubMed     Abstract available

    December 2022
  55. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.

  56. SERA F, Ohtani T, Tamaki S, Yano M, et al
    Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.
    Heart. 2022 Dec 21:heartjnl-2022-321565. doi: 10.1136/heartjnl-2022-321565.
    PubMed     Abstract available

    Diagnosing heart failure with preserved ejection fraction with pulmonary vascular disease.
    Heart. 2022 Dec 21:heartjnl-2022-321984. doi: 10.1136/heartjnl-2022-321984.

  58. CURTAIN JP, Lee MMY, McMurray JJ, Gardner RS, et al
    Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis.
    Heart. 2022 Dec 15:heartjnl-2022-321885. doi: 10.1136/heartjnl-2022-321885.
    PubMed     Abstract available

  59. DAVIS JD
    Too much heterogeneity: envisioning a new approach to methamphetamine associated heart failure.
    Heart. 2022 Dec 1:heartjnl-2022-321919. doi: 10.1136/heartjnl-2022-321919.

  60. MANJA V, Nrusimha A, Gao Y, Sheikh A, et al
    Methamphetamine-associated heart failure: a systematic review of observational studies.
    Heart. 2022 Dec 1:heartjnl-2022-321610. doi: 10.1136/heartjnl-2022-321610.
    PubMed     Abstract available

    November 2022
  61. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed     Abstract available

  62. SAVAGE HO, Dimarco AD, Li B, Langley S, et al
    Sequencing of medical therapy in heart failure with a reduced ejection fraction.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321497. doi: 10.1136/heartjnl-2022-321497
    PubMed     Abstract available

  63. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed     Abstract available

  64. CHIANG CH, Chiang CH, Chiang CH, Ma KS, et al
    Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer.
    Heart. 2022 Nov 9. pii: heartjnl-2022-321545. doi: 10.1136/heartjnl-2022-321545.
    PubMed     Abstract available

    October 2022
  65. OTTO CM
    Heartbeat: sex-specific cardiac microstructural changes in patients with heart failure.
    Heart. 2022;108:1751-1753.

  66. LIANG LW, Raita Y, Hasegawa K, Fifer MA, et al
    Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
    Heart. 2022;108:1807-1814.
    PubMed     Abstract available

  67. RAISI-ESTABRAGH Z, Cooper J, Salih A, Raman B, et al
    Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.
    Heart. 2022 Oct 24. pii: heartjnl-2022-321492. doi: 10.1136/heartjnl-2022-321492
    PubMed     Abstract available

    September 2022
  68. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    PubMed     Abstract available

    August 2022
  69. OU SM, Chao CJ, Tsai MT, Lee KH, et al
    Echocardiographic features of left ventricular dysfunction and outcomes in chronic kidney disease.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321404. doi: 10.1136/heartjnl-2022-321404
    PubMed     Abstract available

  70. HAYDOCK PM, Flett AS
    Management of heart failure with reduced ejection fraction.
    Heart. 2022 Aug 16. pii: heartjnl-2020-318811. doi: 10.1136/heartjnl-2020-318811

  71. MAPELLI M, Salvioni E, Agostoni P
    A strange way of breathing in a patient with advanced systolic heart failure.
    Heart. 2022;108:1391-1420.

  72. KALRA PR, Cleland JG, Petrie MC, Ahmed FZ, et al
    Rationale and design of a randomised trial of intravenous iron in patients with heart failure.
    Heart. 2022 Aug 10. pii: heartjnl-2022-321304. doi: 10.1136/heartjnl-2022-321304
    PubMed     Abstract available

    July 2022
  73. LI J, Zhen Z, Huang P, Dong YG, et al
    Salt restriction and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Heart. 2022 Jul 18. pii: heartjnl-2022-321167. doi: 10.1136/heartjnl-2022-321167
    PubMed     Abstract available

  74. BELZILE D, Senechal M
    Microstructure: a potential path to elucidate sex-specific pathological mechanisms in heart failure?
    Heart. 2022 Jul 14. pii: heartjnl-2022-321250. doi: 10.1136/heartjnl-2022-321250

  75. OTTO CM
    Heartbeat: cardiac resynchronisation therapy pacemaker or defibrillator in patients with heart failure with reduced ejection fraction?
    Heart. 2022;108:1161-1163.

  76. MAILLE B, Bodin A, Bisson A, Herbert J, et al
    Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility score.
    Heart. 2022;108:1186-1193.
    PubMed     Abstract available

  77. STRAW S, Mullens W, Witte KK
    Cardiac resynchronisation therapy with or without a defibrillator: individualising device prescription.
    Heart. 2022;108:1164-1166.

    June 2022
  78. KUMAR R, Rai N, Ahmed AS
    Right heart failure in a young man.
    Heart. 2022;108:1120-1160.

  79. COISNE A, Montaigne D, Ninni S, Lamblin N, et al
    Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis.
    Heart. 2022 Jun 13. pii: heartjnl-2022-320897. doi: 10.1136/heartjnl-2022-320897
    PubMed     Abstract available

  80. KEENAN J, Pal J
    The need for speed: modulating left ventricular assist device flow in response to varying physiological conditions.
    Heart. 2022;108:996-997.

  81. STAPOR M, Pilat A, Gackowski A, Misiuda A, et al
    Echo-guided left ventricular assist device speed optimisation for exercise maximisation.
    Heart. 2022;108:1055-1062.
    PubMed     Abstract available

  82. GIBLETT JP, Williams LK, Moorjani N, Calvert PA, et al
    Percutaneous management of paravalvular leaks.
    Heart. 2022;108:1005-1011.
    PubMed     Abstract available

  83. KWAN A, Demosthenes E, Salto G, Ouyang D, et al
    Cardiac microstructural alterations measured by echocardiography identify sex-specific risk for heart failure.
    Heart. 2022 Jun 9. pii: heartjnl-2022-320876. doi: 10.1136/heartjnl-2022-320876.
    PubMed     Abstract available

  84. TANAKA T, Kavsur R, Spieker M, Iliadis C, et al
    Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
    Heart. 2022 Jun 7. pii: heartjnl-2022-320826. doi: 10.1136/heartjnl-2022-320826.
    PubMed     Abstract available

    May 2022
  85. PARWANI PJ, Van Spall HGC, Mamas M
    Representation of women in heart failure trials: does it matter?
    Heart. 2022 May 17. pii: heartjnl-2022-321094. doi: 10.1136/heartjnl-2022-321094

  86. BHASIN D, Kumar R, Bansal S
    Man with recent myocardial infarction and heart failure.
    Heart. 2022;108:847-898.

  87. KEENE D, Whinnett ZI
    Advances in cardiac resynchronisation therapy: review of indications and delivery options.
    Heart. 2022;108:889-897.

  88. Correction: Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2022 May 5. pii: heartjnl-2021-319229.

  89. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available

    April 2022
  90. BUBER J, Robertson HT
    Cardiopulmonary exercise testing for heart failure: pathophysiology and predictive markers.
    Heart. 2022 Apr 11. pii: heartjnl-2021-319617. doi: 10.1136/heartjnl-2021-319617
    PubMed     Abstract available

  91. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available

    March 2022
  92. MORGAN H, Sinha A, Mcentegart M, Hardman SM, et al
    Evaluation of the causes of sex disparity in heart failure trials.
    Heart. 2022 Mar 31. pii: heartjnl-2021-320696. doi: 10.1136/heartjnl-2021-320696
    PubMed     Abstract available

  93. TAN ESJ, Oon YY, Chan SP, Liew OW, et al
    Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320707. doi: 10.1136/heartjnl-2021-320707
    PubMed     Abstract available

  94. TAKAYA Y, Akagi T, Sakamoto I, Kanazawa H, et al
    Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Heart. 2022;108:382-387.
    PubMed     Abstract available

  95. AYTON SL, Gulsin GS, McCann GP, Moss AJ, et al
    Epicardial adipose tissue in obesity-related cardiac dysfunction.
    Heart. 2022;108:339-344.
    PubMed     Abstract available

    February 2022
  96. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available

    Unusual presentation of cardiogenic shock in a young patient.
    Heart. 2022;108:211-242.

  98. PATEL D, Kumar A, Moennich LA, Trulock K, et al
    Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy.
    Heart. 2022;108:274-278.
    PubMed     Abstract available

  99. BHAGRA SK, Pettit S, Parameshwar J
    Implantable left ventricular assist device: indications, eligibility and current outcomes.
    Heart. 2022;108:233-241.

  100. GREER C, Troughton RW, Adamson PD, Harris SL, et al
    Preterm birth and cardiac function in adulthood.
    Heart. 2022;108:172-177.
    PubMed     Abstract available

  101. AKHTAR AM, Ghouri N, Chahal CAA, Patel R, et al
    Ramadan fasting: recommendations for patients with cardiovascular disease.
    Heart. 2022;108:258-265.
    PubMed     Abstract available

    January 2022
  102. COHEN DJ, Wang K, Magnuson E, Smith R, et al
    Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation.
    Heart. 2022 Jan 25. pii: heartjnl-2021-320005. doi: 10.1136/heartjnl-2021-320005
    PubMed     Abstract available

  103. EMMONS-BELL S, Johnson C, Roth G
    Prevalence, incidence and survival of heart failure: a systematic review.
    Heart. 2022 Jan 18. pii: heartjnl-2021-320131. doi: 10.1136/heartjnl-2021-320131
    PubMed     Abstract available

  104. GEVAERT AB, Kataria R, Zannad F, Sauer AJ, et al
    Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management.
    Heart. 2022 Jan 12. pii: heartjnl-2021-319605. doi: 10.1136/heartjnl-2021-319605
    PubMed     Abstract available

  105. SOTOMI Y, Hikoso S, Komukai S, Sato T, et al
    Phenotyping of acute decompensated heart failure with preserved ejection fraction.
    Heart. 2022 Jan 5. pii: heartjnl-2021-320270. doi: 10.1136/heartjnl-2021-320270.
    PubMed     Abstract available

  106. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.

  107. GULSIN GS, Graham-Brown MPM, Squire IB, Davies MJ, et al
    Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases.
    Heart. 2022;108:16-21.
    PubMed     Abstract available

  108. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available

    December 2021
  109. BROWNRIGG JR, Leo V, Rose J, Low E, et al
    Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
    Heart. 2021 Dec 30. pii: heartjnl-2021-320181. doi: 10.1136/heartjnl-2021-320181
    PubMed     Abstract available

  110. KAPLON-CIESLICKA A, Soloveva A, Mareev Y, Cabac-Pogorevici I, et al
    Hyponatraemia in heart failure: time for new solutions?
    Heart. 2021 Dec 13. pii: heartjnl-2021-320277. doi: 10.1136/heartjnl-2021-320277
    PubMed     Abstract available

  111. GUO X, Song R, Chen Y
    Severe aortic regurgitation and heart failure.
    Heart. 2021;107:1874-1924.

  112. STEINER JM, Cooper S
    Building a career in cardiology and palliative care.
    Heart. 2021;107:1920-1921.

    November 2021
  113. NEDKOFF L, Weber C
    Heart failure: not just a disease of the elderly.
    Heart. 2021 Nov 22. pii: heartjnl-2021-320273. doi: 10.1136/heartjnl-2021-320273

  114. Correction: Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021;107:e15.

  115. ZANDSTRA TE, Nederend M, Jongbloed MRM, Kies P, et al
    Sacubitril/valsartan in the treatment of systemic right ventricular failure.
    Heart. 2021;107:1725-1730.
    PubMed     Abstract available

    October 2021
  116. CHAN DZL, Kerr A, Grey C, Selak V, et al
    Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319853. doi: 10.1136/heartjnl-2021-319853
    PubMed     Abstract available

  117. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986

  118. YALTA K, Ozkan U, Yalta T
    Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al.
    Heart. 2021 Oct 16. pii: heartjnl-2021-320124. doi: 10.1136/heartjnl-2021-320124

  119. JOSHI SS, Singh T, Singh J, Newby DE, et al
    Response to: Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Yalta et al.
    Heart. 2021 Oct 16. pii: heartjnl-2021-320174. doi: 10.1136/heartjnl-2021-320174

  120. LV S, Wang Y, Zhang W, Shang H, et al
    Trimethylamine oxide: a potential target for heart failure therapy.
    Heart. 2021 Oct 5. pii: heartjnl-2021-320054. doi: 10.1136/heartjnl-2021-320054.
    PubMed     Abstract available

  121. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available

    September 2021
  122. RAMOS NASCIMENTO B, Zawacki Beaton A
    Improved standardisation of training needed to achieve the potential of handheld echocardiography.
    Heart. 2021 Sep 27. pii: heartjnl-2021-319945. doi: 10.1136/heartjnl-2021-319945

  123. LIU Y, Tan N, Huo Y, Chen S, et al
    Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
    Heart. 2021 Sep 11. pii: heartjnl-2021-319716. doi: 10.1136/heartjnl-2021-319716
    PubMed     Abstract available

  124. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available

  125. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available

    Failing systemic right ventricle: to treat or not to treat.
    Heart. 2021;107:1360-1361.

    August 2021
  127. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available

  128. HASSAN R, Ahmed SB
    Sex differences in heart failure and precision medicine: right patient, right time...wrong dose?
    Heart. 2021 Aug 18. pii: heartjnl-2021-319831. doi: 10.1136/heartjnl-2021-319831

  129. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available

  130. SINGH A, Agarwal A, Wafford QE, Shah SJ, et al
    Efficacy and safety of diuretics in heart failure with preserved ejection fraction: a scoping review.
    Heart. 2021 Aug 2. pii: heartjnl-2021-319643. doi: 10.1136/heartjnl-2021-319643.
    PubMed     Abstract available

  131. RAMAKUMAR V, Arvind B, Deepti S
    A young man with acute heart failure and a holodiastolic murmur.
    Heart. 2021;107:1288-1356.

    July 2021
  132. BOTS SH, Onland-Moret NC, Tulevski II, van der Harst P, et al
    Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319229. doi: 10.1136/heartjnl-2021-319229
    PubMed     Abstract available

  133. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available

  134. MUDIGONDA P, Berardi C, Chetram V, Barac A, et al
    Implications of cancer prior to and after heart transplantation.
    Heart. 2021 Jul 1. pii: heartjnl-2020-318139. doi: 10.1136/heartjnl-2020-318139.
    PubMed     Abstract available

    June 2021
  135. TAYLOR CJ, Lay-Flurrie SL, Ordonez-Mena JM, Goyder CR, et al
    Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018.
    Heart. 2021 Jun 28. pii: heartjnl-2021-319196. doi: 10.1136/heartjnl-2021-319196
    PubMed     Abstract available

  136. DOCHERTY KF, Petrie MC
    Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
    Heart. 2021 Jun 14. pii: heartjnl-2020-318658. doi: 10.1136/heartjnl-2020-318658

  137. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available

  138. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    PubMed     Abstract available

  139. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.

  140. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.

    May 2021
  141. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available

  142. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available

  143. DESJARDIN J, Leyde S, Davis J
    Weathering the perfect storm: management of heart failure in patients with substance use disorders.
    Heart. 2021 May 24. pii: heartjnl-2021-319103. doi: 10.1136/heartjnl-2021-319103

  144. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available

  145. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145

  146. LADOUCEUR M, Segura de la Cal T, Gaye B, Valentin E, et al
    Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
    Heart. 2021 May 6. pii: heartjnl-2020-318787. doi: 10.1136/heartjnl-2020-318787.
    PubMed     Abstract available

    March 2021
  147. ROMAINE SPR, Denniff M, Codd V, Nath M, et al
    Telomere length is independently associated with all-cause mortality in chronic heart failure.
    Heart. 2021 Mar 31. pii: heartjnl-2020-318654. doi: 10.1136/heartjnl-2020-318654
    PubMed     Abstract available

    Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closer.
    Heart. 2021 Mar 18. pii: heartjnl-2021-319153. doi: 10.1136/heartjnl-2021-319153

  149. AIMO A, Prontera C, Passino C, Emdin M, et al
    Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318791. doi: 10.1136/heartjnl-2020-318791
    PubMed     Abstract available

  150. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available

  151. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available

  152. GUASCH E
    Natriuretic peptides in atrial fibrillation: evidence is here, but are we ready to go one step beyond?
    Heart. 2021 Mar 9. pii: heartjnl-2020-318335. doi: 10.1136/heartjnl-2020-318335.

    February 2021
  153. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    PubMed     Abstract available

    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757

  155. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458

  156. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888

    January 2021
  157. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available

  158. MOHEBALI D, Kittleson MM
    Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318062. doi: 10.1136/heartjnl-2020-318062
    PubMed     Abstract available

  159. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available

  160. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Response to 'Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction'.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318849. doi: 10.1136/heartjnl-2020-318849.

  161. ALBUQUERQUE LL, Meira E Cruz M, Salles C
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318762. doi: 10.1136/heartjnl-2020-318762.

    December 2020
  162. BLACHER M, Zimerman A, Engster PHB, Grespan E, et al
    Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
    Heart. 2020 Dec 23. pii: heartjnl-2020-317984. doi: 10.1136/heartjnl-2020-317984
    PubMed     Abstract available

  163. BURSTEIN DS, Rossano JW, Griffis H, Zhang X, et al
    Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318246. doi: 10.1136/heartjnl-2020-318246
    PubMed     Abstract available

    November 2020
  164. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available

  165. REARDON L, Lin J
    Advanced heart failure and transplant in congenital heart disease.
    Heart. 2020 Nov 13. pii: heartjnl-2019-316366. doi: 10.1136/heartjnl-2019-316366

  166. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2020 Nov 6. pii: heartjnl-2020-317326. doi: 10.1136/heartjnl-2020-317326.
    PubMed     Abstract available

  167. DROZD M, Relton SD, Walker AMN, Slater TA, et al
    Association of heart failure and its comorbidities with loss of life expectancy.
    Heart. 2020 Nov 5. pii: heartjnl-2020-317833. doi: 10.1136/heartjnl-2020-317833.
    PubMed     Abstract available

  168. ZIMERMAN A, Rohde LE
    Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure.
    Heart. 2020 Nov 2. pii: heartjnl-2020-317977. doi: 10.1136/heartjnl-2020-317977.

    October 2020
  169. EGBE A, Miranda W, Connolly H, Dearani J, et al
    Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly.
    Heart. 2020 Oct 29. pii: heartjnl-2020-317756. doi: 10.1136/heartjnl-2020-317756
    PubMed     Abstract available

  170. HUNG CL, Chao TF, Su CH, Liao JN, et al
    Income level and outcomes in patients with heart failure with universal health coverage.
    Heart. 2020 Oct 20. pii: heartjnl-2020-316793. doi: 10.1136/heartjnl-2020-316793
    PubMed     Abstract available

  171. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available

  172. BHATIA HS, Nishimura M, Dickson S, Adler E, et al
    Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
    Heart. 2020 Oct 5. pii: heartjnl-2020-317635. doi: 10.1136/heartjnl-2020-317635.
    PubMed     Abstract available

    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.

    March 2020
  174. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available

  175. CHEN S, Banerjee A
    Machine learning: a long way from implementation in cardiovascular disease.
    Heart. 2020;106:318-320.

    February 2020
  176. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    PubMed     Abstract available

  177. TOBLER D, Greutmann M
    Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
    Heart. 2020;106:307-314.

  178. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.

    August 2019
  179. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.